Table 3. Univariate analysis of factors impacting the incidence of IDC.
| Variables | Assignment | N | Lymphedema case (%) | χ2 | P |
|---|---|---|---|---|---|
| Lymph node metastasis | |||||
| No | 1150 | 102 (8.9) | 14.158 | 0.000 | |
| Yes | 999 | 140 (14.0) | |||
| The number of metastatic lymph nodes | |||||
| ≤3 (N1 Group) | 1746 | 185 (10.6) | 5.583 | 0.054 | |
| 4–9 (N2 Group) | 241 | 30 (12.4) | |||
| ≥10 (N3 Group) | 162 | 27 (16.7) | |||
| Tumor size | |||||
| ≤2cm | 925 | 100 (10.8) | 0.728 | 0.867 | |
| 2–5cm | 1083 | 126 (11.6) | |||
| >5cm | 136 | 15 (11.0) | |||
| Neoadjuvant chemotherapy | |||||
| No | 1755 | 197 (11.2) | 0.143 | 0.931 | |
| Yes | 393 | 45 (11.5) |